This is a national retrospective cohort study with internet-based recruitment whichintends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january2022 will be evaluated in order to assess incidence, potential risk factors and impact ofpost COVID-19 condition according to the WHO definition on health-related quality of lifeand other relevant patient-centered outcomes.
Not Provided
Other: Multiple exposures
Exposures variables (observational study): age, gender, education, comorbidities,
vaccination status, severity of the acute episode of COVID-19, treatments used for acute
COVID-19.
Inclusion Criteria:
- Age ≥ 18 years;
- Brazilian resident;
- Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction
(RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least
90 days before recruitment.
Exclusion Criteria:
- No availability to participate in remote research appointments;
- Communication difficulty (aphasia, important hearing loss, non-portuguese speaker,
severe dementia)
- Refuse to provide informed consent
Inova Medical
Cachoeirinha, RS, Brazil
Investigator: Maicon Falavigna
Maicon Falavigna, MD, PhD
+5551994408818
maicon@inovamedical.com.br
Régis G Rosa, MD, PhD
+5551991303877
regis@inovamedical.com.br
Not Provided